Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:49 PM
Ignite Modification Date:
2025-12-24 @ 2:49 PM
NCT ID:
NCT04923659
Eligibility Criteria:
Inclusion Criteria:
* Right-handed healthy subjects between the ages of 18-65 will be included for recruitment.
Exclusion Criteria:
* Diagnosed with any gait or postural disorders
* Major neurological disease or disorder
* Major musculoskeletal or nerve disorder, or disorder of hands, wrists and upper limbs
* History of stroke or seizure
* Diagnosed with dementia
* Diagnosed with myasthenia gravis or acute narrow angle glaucoma
* Has intracranial implant(s) or device(s)
* Has an implanted cardiac pacemaker or implantable cardioverter-defibrillator (ICD)
* Presence of metal implanted in body that is contraindicated in TMS
* Caffeine or chocolate consumption 1-2 hours before study sessions
* Consumption of grapefruit juice 24 hours before study sessions
* Alcohol consumption 24 hours before study sessions
* Pregnancy\*
* Major depression/psychiatric disorder that in the opinion of the Investigator will affect patient's understanding of study procedures and willingness to abide by all procedures during the course of the study
* Regular usage of CNS active drugs or calcium channel blockers during or up to 2 weeks before participating in the study\*\*
* Is on antipsychotics, marijuana, or other recreational drugs (including tobacco) that affect the nervous system
* Major cardiac, hematopoietic, liver, or kidney disease or infection
* Treated hypertension
* Hypersensitivity to benzodiazepines
* Hypersensitivity to calcium channel blockers
* Hypersensitivity to antitussives
* Hypersensitivity to anticonvulsants
* Regular usage of androgens, antibiotics, antifungals, antivirals, cardiovascular/gastrointestinal drugs, muscle relaxants, and platelet aggregation inhibitors during or up to 2 weeks before participating in the study
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT04923659
Study Brief:
Protocol Section:
NCT04923659